This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

In Vitro Diagnostics Market

Market Insights on In Vitro Diagnostics covering sales outlook, demand forecast & up-to-date key trends

In Vitro Diagnostics Market By Product Type (Reagents & kits, Instruments, Services & software), Technology (Immunodiagnostics, Hematology, Molecular diagnostics, Tissue diagnostics, Clinical chemistry), Application (Infectious diseases, Cancer, Cardiac diseases), End user (Standalone laboratories, Hospitals) & Region - Forecast 2022 - 2032

In Vitro Diagnostics Market Outlook (2022-2032)

[306 Pages Report] During the forecast period, the sales of in-vitro diagnostics hold an average growth prospect with an anticipated CAGR of 3% CAGR from 2022 to 2032, to reach a valuation of US$ 113 Bn by 2026, from US$ 98.2 Bn in 2021.

The need to deliver care locally to the patient is likely to promote a rise in the proportion of testing performed outside of the traditional laboratory in the coming years.

In the last two decades, the list of tests that can be conducted with Point of Care testing devices has grown significantly.

Well-established technologies like lateral flow strips and immunosensors, as well as the continued downsizing of circuits and improved computational capacity of devices, fuelled this growth of in-vitro diagnostic medical devices. This shift from centralized to the point of care testing system is expected to drive the demand for in-vitro diagnostics forward.

Attributes

Details

In-Vitro Diagnostics Market CAGR (2022 – 2032)

3%

In-Vitro Diagnostics Market (2026)

US$ 113 Bn

In-Vitro Diagnostics Market Attraction

Increased frequency of chronic and infectious diseases due to a growing senior population to improve market prospects.

What is the COVID-19 Impact on the In-vitro Diagnostics Market?

The COVID-19 pandemic led to nationwide lockdowns worldwide in order to observe social distancing.

These lockdowns had a great impact on every business in each industry. Similarly, the in-vitro diagnostics market was also affected by the COVID-19 outbreak. 

For instance, the in-vitro diagnostics market faced new challenges such as interrupted supply chains, inconsistent demand for products, and others.

Furthermore, the availability of raw materials and human resources was also impacted. In addition, the in vitro diagnostics industry has seen a demand for new COVID-19 test kits, which is serving as a huge opportunity for the key players in the IVD market

Thus, the overall impact of the COVID-19 pandemic remained positive for the key players in the adoption of the in-vitro diagnostics market. However, few companies are facing a setback due to lockdown, which has led to a drop in the number of IVD tests performed across the globe. 

However, this deleterious impact is being compensated for by the rapid demand for newly launched in vitro diagnostic devices emergency use authorized IVD tests used for COVID-19 detection.

Customize this Report

Let us know your requirement to get
100% FREE customization

What the Primary In-Vitro Diagnostics Market Dynamics?

The frequency of age-related ailments is predicted to rise dramatically as the world's elderly population grows rapidly.

Biomarkers also have a lot of clinical value and interest in the medical business because they can help with illness screening, treatment, and medication.

The accessibility of biomolecular tools and the incorporation of biomarkers are projected to aid in the creation of a new variety of condition-specific tests, giving rise to new in-vitro diagnostics products.

The IVD industry is characterized by fierce competition. As competitors seek to maintain their presence and drive R&D and innovation, the in-vitro diagnostics market adoption is fast evolving with automation, AI, and advanced data analytics.

To fulfil the changing demand for in-vitro diagnostics from providers such as clinical laboratories and point-of-care diagnostic centers, companies have begun to automate diagnostic testing.

With the introduction of quick POC technology, facilities were able to streamline workflows and reduce personnel requirements in order to process a larger sample load.

Diagnostic testing and laboratory industries have banded together to aid public health efforts, provide data for testing, and develop new transformational diagnostic technologies.

What are the Factors Restraining the In-Vitro Diagnostics Market?

Due to the amount of continual technological advancements in medicine, countries with unfavorable reimbursement scenarios have issues in their financial systems.

A few years ago, Medicare in the United States amended its funding method for various in-vitro diagnostic tests, including molecular diagnostic testing.

Some molecular pathology tests don't have their own Healthcare Common Procedure Coding System (HCPCS) codes; thus, they're invoiced with unlisted codes instead. Medicare Administrative Contractors (MACs) set a payment amount for their local jurisdictions in such circumstances.

Molecular diagnostic tests focused on NGS analysis panels and cancer detection tests are among the diagnostics available.

These changes in the reimbursement system are projected to have a negative impact on the molecular and genetic testing market in the United States, stifling the in-vitro diagnostics market growth.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Major Threats Prevalent in the In-Vitro Diagnostics Market?

Clinical laboratories in key markets are still evolving; technicians confront operational issues in assuring effective sample procurement, storage, and transportation, especially as new technologies like NGS and lab-on-a-chip PCR machines become more widely adopted.

In order to reduce cross-contamination and ensure efficient time management, laboratory space must also be modified to fulfill the requirements of conducting certain diagnostic procedures needed for pathogen detection. This drives up the expense of maintaining and operating modern in-vitro diagnostic test kits and instruments, especially those that can only handle a single sample type.

Furthermore, clinical laboratories must implement innovative technology capable of rapid sample diagnosis due to the quick mutation of microorganisms and the increased incidence of epidemics. The lack of competent laboratory professionals to operate modern diagnostic equipment, particularly in emerging areas, has hampered their broad acceptance. 

Another barrier faced by in-vitro diagnostics companies is a reluctance to move away from manual procedures and toward automation. Many providers find it difficult or impossible to make a move from manual or traditional procedures to IT-based approaches.

What are the Opportunities Available to the Market Players in the In-Vitro Diagnostics Market?

Biomarkers and assays for specific diseases are being developed.

The integration of biomarkers and the availability of biomolecular tools are likely to aid in the development of a new set of condition-specific tests, thereby expanding the in-vitro diagnostics industry reach.

The development of new biomarkers for diagnosing various diseases, particularly cancer, has revolutionized medicine. Biomarkers have become more effective in illness identification thanks to advances in sequencing technology and a better understanding of genetics.

As a result, demand for precision medicine is likely to rise, providing considerable potential prospects for in-vitro diagnostics market size growth.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Comparative View of Adjacent In-Vitro Diagnostics Market

In-Vitro Diagnostics Market:

Attributes

In-Vitro Diagnostics Market

CAGR (2022 - 2032)

3%

Market Value (2026)

US$ 113 Bn

Growth Factor

Growing prevalence of chronic diseases due to change in lifestyles and rise in geriatric population

Opportunity

A significant shift from centralized to point of care testing system

Key Trends

A rise in the adoption of fully automated instruments is driving the market forward.

Molecular Diagnostics Market:

Attributes

Molecular Diagnostics Market

CAGR (2022 - 2032)

12%

Market Value (2026)

US$ 32 Bn

Growth Factor

Rising investment in research and development initiatives.

Opportunity

The market for companion diagnostics has a lot of room to develop as interest in high-priced specialist treatments and better medications grows.

Key Trends

The rising incidences of Infectious diseases and cancer globally.

Microfluidics Market:

Attributes

Microfluidics Market

CAGR (2022 - 2032)

23%

Market Value (2026)

US$ 58.8 Bn

Growth Factor

Point of Care diagnostic products, including glucose monitors and pregnancy test kits, are seeing rising demands and usage.

Opportunity

The development of 3D cell culture systems centered on microfluidics.

Key Trends

Increasing need for miniaturizing laboratory equipment and the rising focus on data precision.

As per the global in-vitro diagnostics market study, the industry is expected to increase at a CAGR of 3% throughout the forecast period, reaching a valuation of US$ 113 billion by 2026, up from US$ 98.2 billion in 2021.

The rising frequency of chronic and infectious diseases is responsible for the rise in usage of in-vitro diagnostics medical devices. The rising prevalence of chronic diseases drives the need for extensive diagnostic procedures, which drives the market.

Furthermore, the current in-vitro diagnostics market outlook is positively rising as a result of the IVD market's utilization of modern technology. A paradigm change has occurred, with traditional diagnostics giving way to a new wave of diagnostics that act at the gene level.

The incorporation of modern technologies in the IVD platform, such as genetic testing, molecular diagnostics, polymerase chain reaction (PCR), and next-generation sequencing (NGS), makes this possible.

In addition, the sales of in-vitro diagnostics are likely to be driven by an increase in product introductions with enhanced features.

Which are the Key In-vitro Diagnostics Market Segments?

The industry is fragmented into product and service, technology, application, end user, and region in the report.

The market is subdivided based on product and service: reagents, instruments, services and software. Immunodiagnostics, hematological, molecular diagnostics, tissue diagnostics, clinical chemistry, and others are some of the techniques used.

In 2020, the reagents sector led the in vitro diagnostics market, accounting for 65.3% of total revenue. The rising need for fast, accurate, and sensitive equipment can be contributed to the in vitro diagnostic market expansion of this category.

In addition, their widespread use in in-vitro diagnostic testing, rising demand for self-testing and point-of-care products, and an increase in the number of reagent-related R&D projects are likely to support market expansion.

The application segment is likely to be driven by an increase in market participants developing infectious disease detection tests for in vitro diagnostics. Infectious disease led the market in 2020, accounting for 41.8 percent of total revenue, owing to the rising prevalence of infectious diseases such SARS-CoV-2, HIV, AIDS, TB, and pneumonia.

For example, Siemens Healthineers' 12 novel tests for viral hepatitis and other disorders obtained premarket approval from the US Food and Drug Administration in December 2018. These tests are utilised in the Atellica Solution, which offers hepatitis C screening, diagnosis, and monitoring.

In 2020, the hospital sector led the end-use segment, accounting for 44.2% of total revenue. This is due to an increase in hospitalizations, since clinicians require diagnostic interpretation in order to proceed with therapy.

Diagnostic centers frequently collaborate with hospitals; as a result, hospitals generally have their own diagnostic setup. Furthermore, continued healthcare infrastructure development is expected to improve existing hospital facilities. As a result, the need for in vitro diagnostic tests performed in hospitals is growing.

In 2020, the immunoassay category led the technology segment, accounting for 29.8% of total revenue. It is expected to expand at a rapid rate in the next years as a result of its application in the identification of infectious microorganisms such as fungi, bacteria, and viruses through the detection of their toxins. The highest market share may be ascribed to the rising prevalence of chronic illnesses like HIV and the development of devices with improved precision.

Which are the Key Regions in the In-vitro Diagnostics Market?

The market is perhaps segregated into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

North America is expected to be the largest regional market for in vitro diagnostics during the forecast period, owing to its well-connected healthcare system and increased healthcare awareness among patients, as well as Obama's Affordable Care Act (ACA), technological advancements, and a recovering American economy. 

Other factors that contribute to the market's growth include the widespread availability of devices, increased knowledge about their usage, and the existence of a significant number of senior populations suffering from a variety of chronic ailments.

Furthermore, the presence of a high number of significant companies in North America is a crucial factor driving the in vitro diagnostics market growth.

Moreover, due to an increase in healthcare expenditure and the incidence of diabetes in the region, Asia-Pacific is predicted to expand at the quickest rate throughout the projection period.

Various reasons, such as the large patient population of other chronic illnesses that necessitate IVD testing, also contribute to the Asia-Pacific market's growth.

In terms of IVD market share, Europe is expected to be the second-largest area. Due to increased healthcare expenditures, well-established infrastructure, and the existence of a big pool of patients suffering from infectious illnesses and cancer, Europe maintains a considerable proportion of the market.

How is the Competitive Landscape in the In-vitro Diagnostics Market?

The market for in vitro diagnostics is indeed competitive, with numerous significant competitors. The industry is currently dominated by a few big companies in terms of market share. 

Mid-size to smaller businesses, on the other hand, are expanding their market presence by releasing new items at reduced prices, thanks to technical improvements and product innovations. 

In vitro, diagnostic companies include Thermo Fischer Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, and F. Hoffmann-La Roche AG. 

In addition, important players are active in strategic alliances with firms that complement their product lines, such as acquisitions, collaborations, and partnerships.  

F. Hoffmann-La Roche Ltd. and GenMark Diagnostics, Inc. announced their formal merger agreement in March 2021. Roche will benefit from this purchase by gaining access to GenMark's innovative technology for testing a wide spectrum of infections with a single patient sample.

Becton Dickinson and Company completed the acquisition of NAT Diagnostics in May 2020 to broaden its infectious disease point-of-care testing portfolio.

F. Hoffmann-La Roche Ltd stated in March 2021 that Cobas pure integrated solutions would be available in countries that accept the CE certification.

This innovative compact analyzer integrates three technologies on a single platform to assist small to medium-sized laboratories in streamlining operations.

Siemens Healthineers AG, BD (Becton, Dickinson, and Company), Seegene Inc., DiaSorin S.p.A., and Quest Diagnostics Incorporated are among the other industry participants having a substantial presence in the worldwide market. To grow their market share, these businesses are anticipated to focus on launching new items.

Key Segments

By Product & Service:

  • Reagents
  • Instruments
  • Services & software

By Technology:

  • Immunodiagnostics
  • Hematology
  • Molecular diagnostics
  • Tissue diagnostics
  • Clinical chemistry
  • Others

By Application:

  • Infectious diseases
  • Cancer
  • Cardiac diseases
  • Immune system disorders
  • Nephrological diseases
  • Gastrointestinal diseases
  • Others

By End user:

  • Standalone laboratories
  • Hospitals
  • Academics & Medical Schools
  • Point-of-Care
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

Frequently Asked Questions

Reagents dominated the IVD market with a market share of 65.38% in 2020 owing to a rise in the number of R&D initiatives related to reagents, an increase in the demand for self-test, and Point-of-Care (POC) products.

North America accounts for the largest in vitro diagnostics market share.

The projected value for the sales of in vitro diagnostics is expected to be US$ 91,093 Mn for the forecast year 2027.

Asia Pacific is anticipated to show the fastest overall market growth in the coming years, aided by the growing chronic disease prevalence in the region along with rising healthcare awareness.

The in vitro diagnostics market grows at a rate of 3% CAGR for the forecast periods.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage 

    2.2. Market Definition 

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on In-Vitro Diagnostics

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background 

    4.1. In-Vitro Diagnostics Market, by Key Countries

    4.2. In-Vitro Diagnostics Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. In-Vitro Diagnostics Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. In-Vitro Diagnostics Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global In-Vitro Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global In-Vitro Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product And Service

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product And Service, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product And Service, 2022-2032

        8.3.1. Reagents & Kits

        8.3.2. Instruments

        8.3.3. Services

        8.3.4. Data Management Software

    8.4. Market Attractiveness Analysis By Product And Service

9. Global In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Technology

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032

        9.3.1. Immunoassay/ Immunochemistry

        9.3.2. Clinical chemistry

        9.3.3. Molecular diagnostics

        9.3.4. Hematology

        9.3.5. Microbiology

        9.3.6. Coagulation and Hemostasis

        9.3.7. Urinalysis

        9.3.8. Other Technologies

    9.4. Market Attractiveness Analysis By Technology

10. Global In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Application, 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032

        10.3.1. Infectious diseases

        10.3.2. Diabetes

        10.3.3. Oncology

        10.3.4. Cardiology

        10.3.5. Drug Testing/ Pharmacogenomics

        10.3.6. Autoimmune diseases

        10.3.7. HIV/AIDS

        10.3.8. Nephrology

        10.3.9. Other applications

    10.4. Market Attractiveness Analysis By Application

11. Global In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032

        11.3.1. Hospital laboratories

        11.3.2. Clinical laboratories

        11.3.3. Point-of-care testing centers

        11.3.4. Academic institutes

        11.3.5. Patients

        11.3.6. Other end users

    11.4. Market Attractiveness Analysis By End User

12. Global In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Asia Pacific 

        12.3.5. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. U.S.

            13.4.1.2. Canada

            13.4.1.3. Rest of North America

        13.4.2. By Product And Service

        13.4.3. By Technology

        13.4.4. By End User

        13.4.5. By Application

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product And Service

        13.5.3. By Technology

        13.5.4. By End User

        13.5.5. By Application

14. Latin America In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Brazil

            14.4.1.2. Mexico

            14.4.1.3. Rest of Latin America

        14.4.2. By Product And Service

        14.4.3. By Technology

        14.4.4. By End User

        14.4.5. By Application

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product And Service

        14.5.3. By Technology

        14.5.4. By End User

        14.5.5. By Application

15. Europe In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. Germany

            15.4.1.2. France

            15.4.1.3. U.K.

            15.4.1.4. Italy

            15.4.1.5. Benelux

            15.4.1.6. Nordic Countries

            15.4.1.7. Rest of Europe

        15.4.2. By Product And Service

        15.4.3. By Technology

        15.4.4. By End User

        15.4.5. By Application

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product And Service

        15.5.3. By Technology

        15.5.4. By End User

        15.5.5. By Application

16. Asia Pacific In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. China

            16.4.1.2. Japan

            16.4.1.3. South Korea

            16.4.1.4. Rest of Asia Pacific

        16.4.2. By Product And Service

        16.4.3. By Technology

        16.4.4. By End User

        16.4.5. By Application

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product And Service

        16.5.3. By Technology

        16.5.4. By End User

        16.5.5. By Application

17. Middle East and Africa In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        17.4.1. By Country

            17.4.1.1. GCC Countries

            17.4.1.2. South Africa

            17.4.1.3. Turkey

            17.4.1.4. Rest of Middle East and Africa

        17.4.2. By Product And Service

        17.4.3. By Technology

        17.4.4. By End User

        17.4.5. By Application

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product And Service

        17.5.3. By Technology

        17.5.4. By End User

        17.5.5. By Application

18. Key Countries In-Vitro Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. US In-Vitro Diagnostics Market Analysis

        18.2.1. Value Proportion Analysis by Market Taxonomy

        18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.2.2.1. By Product And Service

            18.2.2.2. By Technology

            18.2.2.3. By End User

            18.2.2.4. By Application

    18.3. Canada In-Vitro Diagnostics Market Analysis

        18.3.1. Value Proportion Analysis by Market Taxonomy

        18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.3.2.1. By Product And Service

            18.3.2.2. By Technology

            18.3.2.3. By End User

            18.3.2.4. By Application

    18.4. Mexico In-Vitro Diagnostics Market Analysis

        18.4.1. Value Proportion Analysis by Market Taxonomy

        18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.4.2.1. By Product And Service

            18.4.2.2. By Technology

            18.4.2.3. By End User

            18.4.2.4. By Application

    18.5. Brazil In-Vitro Diagnostics Market Analysis

        18.5.1. Value Proportion Analysis by Market Taxonomy

        18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.5.2.1. By Product And Service

            18.5.2.2. By Technology

            18.5.2.3. By End User

            18.5.2.4. By Application

    18.6. Germany In-Vitro Diagnostics Market Analysis

        18.6.1. Value Proportion Analysis by Market Taxonomy

        18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.6.2.1. By Product And Service

            18.6.2.2. By Technology

            18.6.2.3. By End User

            18.6.2.4. By Application

    18.7. France In-Vitro Diagnostics Market Analysis

        18.7.1. Value Proportion Analysis by Market Taxonomy

        18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.7.2.1. By Product And Service

            18.7.2.2. By Technology

            18.7.2.3. By End User

            18.7.2.4. By Application

    18.8. Italy In-Vitro Diagnostics Market Analysis

        18.8.1. Value Proportion Analysis by Market Taxonomy

        18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.8.2.1. By Product And Service

            18.8.2.2. By Technology

            18.8.2.3. By End User

            18.8.2.4. By Application

    18.9. BENELUX In-Vitro Diagnostics Market Analysis

        18.9.1. Value Proportion Analysis by Market Taxonomy

        18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.9.2.1. By Product And Service

            18.9.2.2. By Technology

            18.9.2.3. By End User

            18.9.2.4. By Application

    18.10. UK In-Vitro Diagnostics Market Analysis

        18.10.1. Value Proportion Analysis by Market Taxonomy

        18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.10.2.1. By Product And Service

            18.10.2.2. By Technology

            18.10.2.3. By End User

            18.10.2.4. By Application

    18.11. Nordic Countries In-Vitro Diagnostics Market Analysis

        18.11.1. Value Proportion Analysis by Market Taxonomy

        18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.11.2.1. By Product And Service

            18.11.2.2. By Technology

            18.11.2.3. By End User

            18.11.2.4. By Application

    18.12. China In-Vitro Diagnostics Market Analysis

        18.12.1. Value Proportion Analysis by Market Taxonomy

        18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.12.2.1. By Product And Service

            18.12.2.2. By Technology

            18.12.2.3. By End User

            18.12.2.4. By Application

    18.13. Japan In-Vitro Diagnostics Market Analysis

        18.13.1. Value Proportion Analysis by Market Taxonomy

        18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.13.2.1. By Product And Service

            18.13.2.2. By Technology

            18.13.2.3. By End User

            18.13.2.4. By Application

    18.14. South Korea In-Vitro Diagnostics Market Analysis

        18.14.1. Value Proportion Analysis by Market Taxonomy

        18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.14.2.1. By Product And Service

            18.14.2.2. By Technology

            18.14.2.3. By End User

            18.14.2.4. By Application

    18.15. GCC Countries In-Vitro Diagnostics Market Analysis

        18.15.1. Value Proportion Analysis by Market Taxonomy

        18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.15.2.1. By Product And Service

            18.15.2.2. By Technology

            18.15.2.3. By End User

            18.15.2.4. By Application

    18.16. South Africa In-Vitro Diagnostics Market Analysis

        18.16.1. Value Proportion Analysis by Market Taxonomy

        18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.16.2.1. By Product And Service

            18.16.2.2. By Technology

            18.16.2.3. By End User

            18.16.2.4. By Application

    18.17. Turkey In-Vitro Diagnostics Market Analysis

        18.17.1. Value Proportion Analysis by Market Taxonomy

        18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.17.2.1. By Product And Service

            18.17.2.2. By Technology

            18.17.2.3. By End User

            18.17.2.4. By Application

        18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies 

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Product footprint by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive 

        20.3.1. Roche Diagnostics

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Strategy Overview

        20.3.2. Siemens Healthineers

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Strategy Overview

        20.3.3. Danaher Corporation

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Strategy Overview

        20.3.4. Abbott

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Strategy Overview

        20.3.5. Thermo Fisher Scientific

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Strategy Overview

        20.3.6. Johnson & Johnson

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Strategy Overview

        20.3.7. Becton

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Sales Footprint

            20.3.7.4. Strategy Overview

        20.3.8. Dickinson and Company

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Sales Footprint

            20.3.8.4. Strategy Overview

        20.3.9. Bio-Rad Laboratories

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Sales Footprint

            20.3.9.4. Strategy Overview

        20.3.10. Sysmex Corporation

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Sales Footprint

            20.3.10.4. Strategy Overview

        20.3.11. bioMérieux

            20.3.11.1. Overview

            20.3.11.2. Product Portfolio

            20.3.11.3. Sales Footprint

            20.3.11.4. Strategy Overview

        20.3.12. DiaSorin

            20.3.12.1. Overview

            20.3.12.2. Product Portfolio

            20.3.12.3. Sales Footprint

            20.3.12.4. Strategy Overview

        20.3.13. Ortho Clinical Diagnostics

            20.3.13.1. Overview

            20.3.13.2. Product Portfolio

            20.3.13.3. Sales Footprint

            20.3.13.4. Strategy Overview

        20.3.14. QIAGEN N.V.

            20.3.14.1. Overview

            20.3.14.2. Product Portfolio

            20.3.14.3. Sales Footprint

            20.3.14.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2015 – 2021

Table 2: Global In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2022 – 2032

Table 3: Global In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 4: Global In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 5: Global In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2015 – 2021

Table 6: Global In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2022 – 2032

Table 7: Global In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2015 – 2021

Table 8: Global In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2022 – 2032

Table 9: Global In-Vitro Diagnostics Market, By Region, 2015 – 2021

Table 10: Global In-Vitro Diagnostics Market, By Region, 2022 – 2032

Table 11: North America In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2015 – 2021

Table 12: North America In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2022 – 2032

Table 13: North America In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 14: North America In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 15: North America In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2015 – 2021

Table 16: North America In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2022 – 2032

Table 17: North America In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2015 – 2021

Table 18: North America In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2022 – 2032

Table 19: North America In-Vitro Diagnostics Market, By Country, 2015 – 2021

Table 20: North America In-Vitro Diagnostics Market, By Country, 2022 – 2032

Table 21: Latin America In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2015 – 2021

Table 22: Latin America In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2022 – 2032

Table 23: Latin America In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 24: Latin America In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 25: Latin America In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2015 – 2021

Table 26: Latin America In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2022 – 2032

Table 27: Latin America In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2015 – 2021

Table 28: Latin America In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2022 – 2032

Table 29: Latin America In-Vitro Diagnostics Market, By Country, 2015 – 2021

Table 30: Latin America In-Vitro Diagnostics Market, By Country, 2022 – 2032

Table 31: Europe In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2015 – 2021

Table 32: Europe In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2022 – 2032

Table 33: Europe In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 34: Europe In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 35: Europe In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2015 – 2021

Table 36: Europe In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2022 – 2032

Table 37: Europe In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2015 – 2021

Table 38: Europe In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2022 – 2032

Table 39: Europe In-Vitro Diagnostics Market, By Country, 2015 – 2021

Table 40: Europe In-Vitro Diagnostics Market, By Country, 2022 – 2032

Table 41: Asia Pacific In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2015 – 2021

Table 42: Asia Pacific In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2022 – 2032

Table 43: Asia Pacific In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 44: Asia Pacific In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 45: Asia Pacific In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2015 – 2021

Table 46: Asia Pacific In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2022 – 2032

Table 47: Asia Pacific In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2015 – 2021

Table 48: Asia Pacific In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2022 – 2032

Table 49: Asia Pacific In-Vitro Diagnostics Market, By Country, 2015 – 2021

Table 50: Asia Pacific In-Vitro Diagnostics Market, By Country, 2022 – 2032

Table 51: MEA In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2015 – 2021

Table 52: MEA In-Vitro Diagnostics Market Value (US$ Mn),By Product And Service, 2022 – 2032

Table 53: MEA In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2015 – 2021

Table 54: MEA In-Vitro Diagnostics Market Value (US$ Mn), By Technology, 2022 – 2032

Table 55: MEA In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2015 – 2021

Table 56: MEA In-Vitro Diagnostics Market Value (US$ Mn), By Application, 2022 – 2032

Table 57: MEA In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2015 – 2021

Table 58: MEA In-Vitro Diagnostics Market Value (US$ Mn), By End User, 2022 – 2032

Table 59: MEA In-Vitro Diagnostics Market, By Country, 2015 – 2021

Table 60: MEA In-Vitro Diagnostics Market, By Country, 2022 – 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global In-Vitro Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global In-Vitro Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global In-Vitro Diagnostics Market Share, By Product And Service, 2022 & 2032

Figure 4: Global In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Product And Service – 2022-2032

Figure 5: Global In-Vitro Diagnostics Market Attractiveness Index, By Product And Service – 2022-2032

Figure 6: Global In-Vitro Diagnostics Market Share, By Technology, 2022 & 2032

Figure 7: Global In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 8: Global In-Vitro Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 9: Global In-Vitro Diagnostics Market Share, By End User, 2022 & 2032

Figure 10: Global In-Vitro Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 11: Global In-Vitro Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 12: Global In-Vitro Diagnostics Market Share, By Application, 2022 & 2032

Figure 13: Global In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 14: Global In-Vitro Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 15: Global In-Vitro Diagnostics Market Share, By Region, 2022 & 2032

Figure 16: Global In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 17: Global In-Vitro Diagnostics Market Attractiveness Index, By Region – 2022-2032

Figure 18: North America In-Vitro Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 19: North America In-Vitro Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 20: North America In-Vitro Diagnostics Market Share, By Product And Service, 2022 & 2032

Figure 21: North America In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Product And Service – 2022-2032

Figure 22: North America In-Vitro Diagnostics Market Attractiveness Index, By Product And Service – 2022-2032

Figure 23: North America In-Vitro Diagnostics Market Share, By Technology, 2022 & 2032

Figure 24: North America In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 25: North America In-Vitro Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 26: North America In-Vitro Diagnostics Market Share, By End User, 2022 & 2032

Figure 27: North America In-Vitro Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 28: North America In-Vitro Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 29: North America In-Vitro Diagnostics Market Share, By Application, 2022 & 2032

Figure 30: North America In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 31: North America In-Vitro Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 32: North America In-Vitro Diagnostics Market Share, By Country, 2022 & 2032

Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 34: North America Market Attractiveness Index, By Country – 2022-2032

Figure 35: Latin America In-Vitro Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 36: Latin America In-Vitro Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 37: Latin America In-Vitro Diagnostics Market Share, By Product And Service, 2022 & 2032

Figure 38: Latin America In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Product And Service – 2022-2032

Figure 39: Latin America In-Vitro Diagnostics Market Attractiveness Index, By Product And Service – 2022-2032

Figure 40: Latin America In-Vitro Diagnostics Market Share, By Technology, 2022 & 2032

Figure 41: Latin America In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 42: Latin America In-Vitro Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 43: Latin America In-Vitro Diagnostics Market Share, By End User, 2022 & 2032

Figure 44: Latin America In-Vitro Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 45: Latin America In-Vitro Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 46: Latin America In-Vitro Diagnostics Market Share, By Application, 2022 & 2032

Figure 47: Latin America In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 48: Latin America In-Vitro Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 49: Latin America In-Vitro Diagnostics Market Share, By Country, 2022 & 2032

Figure 50: Latin America In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 51: Latin America In-Vitro Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 52: Europe In-Vitro Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 53: Europe In-Vitro Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 54: Europe In-Vitro Diagnostics Market Share, By Product And Service, 2022 & 2032

Figure 55: Europe In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Product And Service – 2022-2032

Figure 56: Europe In-Vitro Diagnostics Market Attractiveness Index, By Product And Service – 2022-2032

Figure 57: Europe In-Vitro Diagnostics Market Share, By Technology, 2022 & 2032

Figure 58: Europe In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 59: Europe In-Vitro Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 60: Europe In-Vitro Diagnostics Market Share, By End User, 2022 & 2032

Figure 61: Europe In-Vitro Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 62: Europe In-Vitro Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 63: Europe In-Vitro Diagnostics Market Share, By Application, 2022 & 2032

Figure 64: Europe In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 65: Europe In-Vitro Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 66: Europe In-Vitro Diagnostics Market Share, By Country, 2022 & 2032

Figure 67: Europe In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 68: Europe In-Vitro Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 69: MEA In-Vitro Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 70: MEA In-Vitro Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 71: MEA In-Vitro Diagnostics Market Share, By Product And Service, 2022 & 2032

Figure 72: MEA In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Product And Service – 2022-2032

Figure 73: MEA In-Vitro Diagnostics Market Attractiveness Index, By Product And Service – 2022-2032

Figure 74: MEA In-Vitro Diagnostics Market Share, By Technology, 2022 & 2032

Figure 75: MEA In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 76: MEA In-Vitro Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 77: MEA In-Vitro Diagnostics Market Share, By End User, 2022 & 2032

Figure 78: MEA In-Vitro Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 79: MEA In-Vitro Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 80: MEA In-Vitro Diagnostics Market Share, By Application, 2022 & 2032

Figure 81: MEA In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 82: MEA In-Vitro Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 83: MEA In-Vitro Diagnostics Market Share, By Country, 2022 & 2032

Figure 84: MEA In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 85: MEA In-Vitro Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 86: Asia Pacific In-Vitro Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 87: Asia Pacific In-Vitro Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 88: Asia Pacific In-Vitro Diagnostics Market Share, By Product And Service, 2022 & 2032

Figure 89: Asia Pacific In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Product And Service – 2022-2032

Figure 90: Asia Pacific In-Vitro Diagnostics Market Attractiveness Index, By Product And Service – 2022-2032

Figure 91: Asia Pacific In-Vitro Diagnostics Market Share, By Technology, 2022 & 2032

Figure 92: Asia Pacific In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 93: Asia Pacific In-Vitro Diagnostics Market Attractiveness Index, By Technology – 2022-2032

Figure 94: Asia Pacific In-Vitro Diagnostics Market Share, By End User, 2022 & 2032

Figure 95: Asia Pacific In-Vitro Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 96: Asia Pacific In-Vitro Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 97: Asia Pacific In-Vitro Diagnostics Market Share, By Application, 2022 & 2032

Figure 98: Asia Pacific In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 99: Asia Pacific In-Vitro Diagnostics Market Attractiveness Index, By Application – 2022-2032

Figure 100: Asia Pacific In-Vitro Diagnostics Market Share, By Country, 2022 & 2032

Figure 101: Asia Pacific In-Vitro Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 102: Asia Pacific In-Vitro Diagnostics Market Attractiveness Index, By Country – 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

In Vitro Diagnostics Market